Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment

NCT04396223 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
26
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospices Civils de Lyon

Collaborators